Publications by authors named "Kohei Kawajiri"
Article Synopsis
- Tachyarrhythmia treatments currently include drug therapy, catheter ablation, and implantable devices, but there's a need for more effective solutions as existing methods have limitations.
- Recent developments in gene therapy are being explored as a possible innovative approach for treating drug-refractory tachyarrhythmias.
- While gene therapy shows promise, further advancements are necessary to ensure safe and effective gene delivery for real-world use in clinical settings.
Background: Ventricular arrhythmia inducibility is one of the ideal endpoints of ventricular tachycardia (VT) ablation. However, it may be challenging to implement programmed electrical stimulation (PES) at the end of the procedure under several circumstances. The long-term outcome of patients who did not undergo PES after VT ablation remains largely unknown.
View Article and Find Full Text PDFA 17-year-old woman presented with frequent palpitations and shortness of breath and was diagnosed with drug-refractory ventricular parasystole. We predicted that the parasystole originated from the left anterior fascicle (LAF). Detailed activation maps of both conduction systems, including the LAF, during sinus rhythm and ventricular parasystole were obtained using a parallel mapping system.
View Article and Find Full Text PDFBackground: Different subtypes of ischemic stroke may have different risk factors, clinical features, and prognoses. This study investigated the incidence and mode of stroke recurrence in patients with a history of stroke who underwent atrial fibrillation (AF) ablation.
Methods: Of 825 patients who underwent AF ablation from 2006 to 2016, 77 patients (9.